Bihale Inhalation Capsule 25 mcg+200 mcg is a fixed-dose combination inhalation therapy containing Vilanterol Trifenatate and Fluticasone Furoate. It is formulated for the long-term maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). This medicine works by improving airflow, reducing airway inflammation, and helping patients achieve better control of chronic respiratory symptoms when used regularly.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each inhalation capsule contains:

• Vilanterol Trifenatate 25 mcg

• Fluticasone Furoate 200 mcg

Therapeutic Class

• Long-acting beta₂-adrenergic agonist (LABA)

• Inhaled corticosteroid (ICS)

Pharmacology and Mechanism of Action

Bihale Inhalation Capsule combines two well-established respiratory agents with complementary mechanisms of action. Vilanterol Trifenatate is a highly selective, long-acting beta₂-agonist that produces sustained relaxation of bronchial smooth muscle. This bronchodilatory effect helps keep the airways open, reducing airflow limitation and easing breathing over a prolonged period.

Fluticasone Furoate is a potent inhaled corticosteroid with strong anti-inflammatory activity. It works by inhibiting multiple inflammatory pathways involved in asthma and COPD, thereby decreasing airway swelling, mucus secretion, and hypersensitivity. The higher 200 mcg strength of fluticasone furoate is particularly beneficial for patients with moderate to severe disease who require enhanced anti-inflammatory control.

Together, these two components provide comprehensive management by addressing both bronchoconstriction and underlying airway inflammation.

Indications

Bihale Inhalation Capsule 25 mcg+200 mcg is indicated for:

• Maintenance treatment of asthma in patients inadequately controlled on lower-dose inhaled corticosteroids

• Long-term management of COPD, including chronic bronchitis and emphysema

• Prevention of exacerbations and improvement of lung function and symptom control

This product is not intended for the treatment of acute bronchospasm or sudden breathing attacks.

Dosage and Administration

Bihale Inhalation Capsule is intended for inhalation use only with a suitable dry powder inhaler device. The usual recommended dose is one capsule inhaled once daily, or as prescribed by a physician. Proper inhalation technique is essential to ensure effective drug delivery to the lungs.

Key Benefits

• Provides long-lasting bronchodilation for improved airflow

• Delivers strong anti-inflammatory action for better disease control

• Helps reduce frequency and severity of asthma or COPD exacerbations

• Once-daily dosing enhances patient compliance

• Suitable for long-term maintenance therapy

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Not suitable for relief of acute asthma or COPD attacks

• Use with caution in patients with cardiovascular disorders, active infections, or compromised immunity

• Rinsing the mouth after inhalation is recommended to minimize the risk of oral fungal infections

• Use during pregnancy and lactation should be based on medical advice

Storage

Store below 30°C in a dry place. Protect from moisture and direct sunlight. Keep out of reach of children.